Variant report
Variant | rs11229798 |
---|---|
Chromosome Location | chr11:58864267-58864268 |
allele | A/C |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:58863409..58866220-chr11:58910202..58912249,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000245571 | Chromatin interaction |
ENSG00000166801 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10128559 | 0.95[ASN][1000 genomes] |
rs10128661 | 0.83[EUR][1000 genomes] |
rs10437720 | 0.94[CEU][hapmap];0.92[EUR][1000 genomes] |
rs10792211 | 0.88[YRI][hapmap] |
rs10792219 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.80[AFR][1000 genomes];0.96[AMR][1000 genomes];0.97[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs10792221 | 0.85[CEU][hapmap];0.89[EUR][1000 genomes] |
rs10896914 | 0.85[AFR][1000 genomes];0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10896922 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.80[AFR][1000 genomes];0.96[AMR][1000 genomes];0.97[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs10896924 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.80[AFR][1000 genomes];0.96[AMR][1000 genomes];0.95[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs10896925 | 0.94[CEU][hapmap];0.92[EUR][1000 genomes] |
rs10896926 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.90[EUR][1000 genomes] |
rs10896928 | 0.94[CEU][hapmap];0.90[EUR][1000 genomes] |
rs10896929 | 0.87[CEU][hapmap];1.00[CHB][hapmap];0.89[EUR][1000 genomes] |
rs10896930 | 0.89[EUR][1000 genomes] |
rs10896931 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.92[EUR][1000 genomes] |
rs10896932 | 0.90[CHB][hapmap];0.89[EUR][1000 genomes] |
rs10896933 | 0.88[EUR][1000 genomes] |
rs10896934 | 0.83[EUR][1000 genomes] |
rs10896935 | 0.81[EUR][1000 genomes] |
rs10896936 | 0.88[EUR][1000 genomes] |
rs10896937 | 0.88[EUR][1000 genomes] |
rs10896938 | 0.80[EUR][1000 genomes] |
rs10896947 | 0.94[CEU][hapmap] |
rs11229795 | 0.95[AFR][1000 genomes];0.95[ASN][1000 genomes] |
rs11229799 | 0.93[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11229800 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11229801 | 0.80[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11229837 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.90[EUR][1000 genomes] |
rs11229840 | 0.94[CEU][hapmap];0.88[EUR][1000 genomes] |
rs11229848 | 0.81[CEU][hapmap];0.86[EUR][1000 genomes] |
rs11229849 | 0.94[CEU][hapmap];0.89[EUR][1000 genomes] |
rs11229850 | 0.87[CEU][hapmap];0.91[CHB][hapmap] |
rs11229851 | 0.89[EUR][1000 genomes] |
rs11229852 | 0.89[EUR][1000 genomes] |
rs11229854 | 0.89[EUR][1000 genomes] |
rs11229856 | 0.88[EUR][1000 genomes] |
rs11823977 | 0.80[AFR][1000 genomes];0.96[AMR][1000 genomes];0.95[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs11825017 | 0.80[AFR][1000 genomes];0.96[AMR][1000 genomes];0.95[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs12271831 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.90[EUR][1000 genomes] |
rs12272113 | 0.89[EUR][1000 genomes] |
rs12274008 | 0.87[CEU][hapmap];1.00[CHB][hapmap];0.89[EUR][1000 genomes] |
rs12275487 | 0.87[CEU][hapmap];0.91[CHB][hapmap];0.87[EUR][1000 genomes] |
rs12278163 | 0.86[CEU][hapmap];1.00[CHB][hapmap];0.89[EUR][1000 genomes] |
rs12280068 | 0.87[CEU][hapmap];0.91[CHB][hapmap];0.89[EUR][1000 genomes] |
rs12283633 | 0.87[CEU][hapmap];1.00[CHB][hapmap];0.89[EUR][1000 genomes] |
rs12290612 | 0.90[YRI][hapmap] |
rs12292185 | 0.87[EUR][1000 genomes] |
rs12292779 | 1.00[YRI][hapmap] |
rs12293649 | 0.87[CEU][hapmap];1.00[CHB][hapmap];0.89[EUR][1000 genomes] |
rs12293695 | 0.87[CEU][hapmap];0.89[EUR][1000 genomes] |
rs12362905 | 0.89[EUR][1000 genomes] |
rs12802129 | 0.80[AFR][1000 genomes];0.96[AMR][1000 genomes];0.95[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs17153379 | 0.95[AFR][1000 genomes];0.96[AMR][1000 genomes];0.95[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs17153383 | 0.92[EUR][1000 genomes] |
rs17153415 | 0.86[EUR][1000 genomes] |
rs1938588 | 0.80[AFR][1000 genomes];0.96[AMR][1000 genomes];0.95[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs1938589 | 0.92[EUR][1000 genomes] |
rs1938781 | 0.94[CEU][hapmap];0.90[EUR][1000 genomes] |
rs1943146 | 0.92[ASN][1000 genomes] |
rs1943147 | 0.92[ASN][1000 genomes] |
rs2096544 | 0.89[EUR][1000 genomes] |
rs2096586 | 0.83[EUR][1000 genomes] |
rs2096587 | 0.86[EUR][1000 genomes] |
rs2105506 | 0.87[CEU][hapmap];1.00[CHB][hapmap];0.89[EUR][1000 genomes] |
rs2105507 | 0.89[EUR][1000 genomes] |
rs2154628 | 0.81[CEU][hapmap];0.81[EUR][1000 genomes] |
rs2186380 | 0.85[CEU][hapmap];0.89[EUR][1000 genomes] |
rs2282482 | 0.80[AFR][1000 genomes];0.96[AMR][1000 genomes];0.97[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs2282483 | 0.96[AMR][1000 genomes];0.96[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs2839968 | 0.94[CEU][hapmap] |
rs2844342 | 0.94[ASN][1000 genomes] |
rs2849739 | 0.82[AMR][1000 genomes];0.92[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs34027305 | 0.90[EUR][1000 genomes] |
rs34239454 | 0.85[AFR][1000 genomes];0.96[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs34501069 | 0.89[EUR][1000 genomes] |
rs35293773 | 0.85[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs3802961 | 0.80[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs474847 | 0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs530386 | 0.85[AFR][1000 genomes];0.87[ASN][1000 genomes] |
rs55657403 | 0.83[EUR][1000 genomes] |
rs55689653 | 0.89[EUR][1000 genomes] |
rs55989038 | 0.81[EUR][1000 genomes] |
rs56137001 | 0.89[EUR][1000 genomes] |
rs56239606 | 0.82[EUR][1000 genomes] |
rs58722008 | 0.86[EUR][1000 genomes] |
rs61902181 | 0.89[EUR][1000 genomes] |
rs61902223 | 0.89[EUR][1000 genomes] |
rs7126078 | 0.80[AFR][1000 genomes];0.96[AMR][1000 genomes];0.95[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs7933787 | 0.94[CEU][hapmap];0.89[EUR][1000 genomes] |
rs7950880 | 0.80[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1050013 | chr11:58394598-59221090 | Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer ZNF genes & repeats Genic enhancers Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 67 gene(s) | inside rSNPs | diseases |
2 | nsv948365 | chr11:58515163-59156405 | Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Strong transcription Genic enhancers Enhancers Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 59 gene(s) | inside rSNPs | diseases |
3 | esv3393019 | chr11:58679419-58880845 | Flanking Active TSS Active TSS Enhancers ZNF genes & repeats Bivalent Enhancer Weak transcription Bivalent/Poised TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
4 | nsv428258 | chr11:58700092-58878839 | Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent/Poised TSS Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
5 | esv2758272 | chr11:58700092-59008673 | Bivalent/Poised TSS Active TSS Weak transcription Enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 44 gene(s) | inside rSNPs | diseases |
6 | esv2759830 | chr11:58700092-59008673 | Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 44 gene(s) | inside rSNPs | diseases |
7 | nsv832171 | chr11:58725930-58878839 | Bivalent Enhancer Weak transcription Strong transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 15 gene(s) | inside rSNPs | diseases |
8 | nsv469559 | chr11:58730785-58887639 | Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers ZNF genes & repeats Weak transcription Bivalent/Poised TSS Genic enhancers Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 15 gene(s) | inside rSNPs | diseases |
9 | nsv482906 | chr11:58730785-58887639 | Enhancers Active TSS ZNF genes & repeats Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 15 gene(s) | inside rSNPs | diseases |
10 | nsv471671 | chr11:58730786-58887639 | Active TSS Weak transcription Enhancers ZNF genes & repeats Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 15 gene(s) | inside rSNPs | diseases |
11 | esv2757447 | chr11:58746238-58906018 | Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS ZNF genes & repeats Flanking Active TSS Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 22 gene(s) | inside rSNPs | diseases |
12 | nsv975329 | chr11:58767290-58907813 | Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 25 gene(s) | inside rSNPs | diseases |
13 | nsv430388 | chr11:58769524-58925824 | Enhancers Active TSS ZNF genes & repeats Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 32 gene(s) | inside rSNPs | diseases |
14 | nsv468578 | chr11:58790628-58901763 | ZNF genes & repeats Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 15 gene(s) | inside rSNPs | diseases |
15 | nsv555147 | chr11:58790628-58901763 | Active TSS Flanking Active TSS Strong transcription Enhancers Genic enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 15 gene(s) | inside rSNPs | diseases |
16 | nsv1050767 | chr11:58790982-58864544 | Enhancers Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
17 | esv2760644 | chr11:58798999-58869223 | Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Strong transcription Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
18 | nsv1039379 | chr11:58800374-58864544 | Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS Strong transcription Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
19 | nsv1045695 | chr11:58811241-58864544 | Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription Genic enhancers Strong transcription Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 5 gene(s) | inside rSNPs | diseases |
20 | nsv1043956 | chr11:58818144-58882570 | Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
21 | esv3381644 | chr11:58822364-58866298 | Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 5 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:58858200-58869000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr11:58860000-58864600 | Genic enhancers | Primary B cells from peripheral blood | blood |
3 | chr11:58860000-58869000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr11:58861400-58866400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr11:58863000-58867000 | Enhancers | H1 Cell Line | embryonic stem cell |
6 | chr11:58863200-58864600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
7 | chr11:58863200-58866400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr11:58863200-58866400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr11:58863200-58869600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr11:58863400-58866000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
11 | chr11:58863600-58864400 | Enhancers | GM12878-XiMat | blood |
12 | chr11:58864000-58864400 | Enhancers | H9 Cell Line | embryonic stem cell |
13 | chr11:58864000-58865200 | Flanking Active TSS | Primary B cells from cord blood | blood |
14 | chr11:58864000-58867000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr11:58864200-58866000 | Enhancers | HUES6 Cell Line | embryonic stem cell |